Delivery Order SPE2DB24D8001-SPE2DB25FLAFV
- Not listed
- The Defense Logistics Agency awarded a $1,812.09 delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed price delivery order with no set-aside designation. This delivery is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) valued at $999,999,999.00 through the...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, has been awarded a delivery order valued at $3,648.73 for Zepbound 15 mg/0.5 mL pens by the Defense Logistics Agency on August 7, 2025. The contract, designated as firm fixed price with no set-aside designation, represents a delivery under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) valued at $999,999,999.00 with the DLA Troop Support Medical's ECAT Generation V Program, which...
- The Defense Logistics Agency awarded a $2,339.75 firm fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Zepbound 15 mg/0.5 ml pen injections. The delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, carries no set-aside designation and represents a continuation of Dakota Drug's role as a critical pharmaceutical supplier to the military healthcare system. This award...
- The Defense Logistics Agency awarded a $3,790.34 delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, on June 5, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors. This firm fixed-price delivery order is set to be completed by June 6, 2025, with performance taking place in Anoka, Minnesota. The award carries no set-aside designation and represents a single delivery under Dakota Drug's broader contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $4,997.29 to Dakota Drug, Inc., a self-certified small disadvantaged business headquartered in Anoka, Minnesota, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025, and represents part of the company's broader pharmaceutical and medical supply relationship with the federal government. The award carries no...
- Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, received a delivery order from the Defense Logistics Agency valued at $11,832.92 for Zepbound 5 mg/0.5 mL pens. The award, issued on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order falls under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed-price delivery order, valued at $1,249.72, is scheduled for completion by June 3, 2025, and will be performed at the contractor's Anoka, Minnesota facility. The award represents no set-aside designation and falls under Dakota Drug, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,683.96 firm fixed price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Zepbound 15 mg/0.5 mL pens. The delivery order, issued on June 26, 2025, with an ultimate completion date of June 27, 2025, represents a direct fulfillment under the company's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program. This delivery...
- The Defense Logistics Agency awarded a $6,672.92 delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, on July 14, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. The contract represents a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and carries no set-aside designation. This award falls under Dakota Drug's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT...
- The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Zepbound 15 mg/0.5 mL pen injections. This firm fixed-price delivery order, valued at $2,071.95, was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The award carries no set-aside designation and represents a direct procurement of pharmaceutical products to support U.S. Armed Forces medical...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLAFVDelivery Order
Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Zepbound 15 mg/0.5 ml pen injections. The contract, valued at $2,116.75, represents a Firm Fixed Price delivery order with an ultimate completion date of August 18, 2025. This award was made without a set-aside designation and fulfills pharmaceutical supply requirements for U.S. Armed Forces medical operations. The delivery order is issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, a comprehensive $999,999,999.00 vehicle that runs through December 31, 2025. The ECAT Generation V Program is designed to provide commercial medical equipment, accessories, consumables, and medical supplies to support military healthcare facilities. Under this delivery order, Dakota Drug, Inc. will supply the diabetes management medication Zepbound to fulfill DLA requirements. The company has established itself as a critical vendor in the federal pharmaceutical supply chain, with an extensive history of delivering diverse medical products including insulin, respiratory medications, cardiovascular drugs, and vaccines to defense healthcare facilities. The work will be performed in Anoka, Minnesota, leveraging the contractor's established capabilities in pharmaceutical distribution to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/15/25 |